PubMed:22143985
Annnotations
Glycan-Motif
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 12-27 | https://glytoucan.org/Structures/Glycans/G57321FI | denotes | Tn antigenicity |
T2 | 123-133 | https://glytoucan.org/Structures/Glycans/G57321FI | denotes | Tn antigen |
T3 | 162-183 | https://glytoucan.org/Structures/Glycans/G27025MB | denotes | N-acetylgalactosamine |
T4 | 317-327 | https://glytoucan.org/Structures/Glycans/G57321FI | denotes | Tn antigen |
T5 | 411-426 | https://glytoucan.org/Structures/Glycans/G57321FI | denotes | Tn antigenicity |
T6 | 604-614 | https://glytoucan.org/Structures/Glycans/G57321FI | denotes | Tn antigen |
T7 | 1048-1058 | https://glytoucan.org/Structures/Glycans/G57321FI | denotes | Tn antigen |
T8 | 1178-1188 | https://glytoucan.org/Structures/Glycans/G57321FI | denotes | Tn antigen |
T9 | 1567-1577 | https://glytoucan.org/Structures/Glycans/G57321FI | denotes | Tn antigen |
T10 | 1642-1652 | https://glytoucan.org/Structures/Glycans/G57321FI | denotes | Tn antigen |
GlyCosmos6-Glycan-Motif-Image
Id | Subject | Object | Predicate | Lexical cue | image |
---|---|---|---|---|---|
T1 | 12-27 | Glycan_Motif | denotes | Tn antigenicity | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G57321FI |
T2 | 123-133 | Glycan_Motif | denotes | Tn antigen | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G57321FI |
T3 | 162-183 | Glycan_Motif | denotes | N-acetylgalactosamine | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G27025MB |
T4 | 317-327 | Glycan_Motif | denotes | Tn antigen | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G57321FI |
T5 | 411-426 | Glycan_Motif | denotes | Tn antigenicity | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G57321FI |
T6 | 604-614 | Glycan_Motif | denotes | Tn antigen | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G57321FI |
T7 | 1048-1058 | Glycan_Motif | denotes | Tn antigen | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G57321FI |
T8 | 1178-1188 | Glycan_Motif | denotes | Tn antigen | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G57321FI |
T9 | 1567-1577 | Glycan_Motif | denotes | Tn antigen | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G57321FI |
T10 | 1642-1652 | Glycan_Motif | denotes | Tn antigen | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G57321FI |
sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
TextSentencer_T1 | 0-113 | Sentence | denotes | Analysis of Tn antigenicity with a panel of new IgM and IgG1 monoclonal antibodies raised against leukemic cells. |
TextSentencer_T2 | 114-277 | Sentence | denotes | CD175 or Tn antigen is a carbohydrate moiety of N-acetylgalactosamine (GalNAc)α1-O- linked to the residue of amino acid serine or threonine in a polypeptide chain. |
TextSentencer_T3 | 278-452 | Sentence | denotes | Despite the chemical simplicity of the Tn antigen, its antigenic structure is considered to be complex and the clear determinants of Tn antigenicity remain poorly understood. |
TextSentencer_T4 | 453-547 | Sentence | denotes | As a consequence, a broad variety of anti-Tn monoclonal antibodies (mAbs) have been generated. |
TextSentencer_T5 | 548-819 | Sentence | denotes | To further investigate the nature and complexity of the Tn antigen, we generated seven different anti-Tn mAbs of IgM and IgG classes raised against human Jurkat T cells, which are Tn-positive due to the low activity of T-synthase and mutation in specific chaperone Cosmc. |
TextSentencer_T6 | 820-997 | Sentence | denotes | The binding analysis of anti-Tn mAbs with the array of synthetic saccharides, glycopeptides and O-glycoproteins revealed unexpected differences in specificities of anti-Tn mAbs. |
TextSentencer_T7 | 998-1140 | Sentence | denotes | IgM mAbs bound the terminal GalNAc residue of the Tn antigen irrespective of the peptide context or with low selectivity to the glycoproteins. |
TextSentencer_T8 | 1141-1232 | Sentence | denotes | In contrast, IgG mAbs recognized the Tn antigen in the context of a specific peptide motif. |
TextSentencer_T9 | 1233-1373 | Sentence | denotes | Particularly, JA3 mAb reacted to the GSPP or GSPAPP, and JA5 mAb recognized specifically the GSP motif (glycosylation sites are underlined). |
TextSentencer_T10 | 1374-1532 | Sentence | denotes | The major O-glycan carrier proteins CD43 and CD162 and isoforms of CD45 expressed on Jurkat cells were precipitated by anti-Tn mAbs with different affinities. |
TextSentencer_T11 | 1533-1718 | Sentence | denotes | In summary, our data suggest that Tn antigen-Ab binding capacity is determined by the peptide context of the Tn antigen, antigenic specificity of the Ab and class of the immunoglobulin. |
TextSentencer_T12 | 1719-1893 | Sentence | denotes | The newly generated anti-Tn IgG mAbs with the strong specificity to glycoprotein CD43 can be particularly interesting for the application in leukemia diagnostics and therapy. |
T1 | 0-113 | Sentence | denotes | Analysis of Tn antigenicity with a panel of new IgM and IgG1 monoclonal antibodies raised against leukemic cells. |
T2 | 114-277 | Sentence | denotes | CD175 or Tn antigen is a carbohydrate moiety of N-acetylgalactosamine (GalNAc)α1-O- linked to the residue of amino acid serine or threonine in a polypeptide chain. |
T3 | 278-452 | Sentence | denotes | Despite the chemical simplicity of the Tn antigen, its antigenic structure is considered to be complex and the clear determinants of Tn antigenicity remain poorly understood. |
T4 | 453-547 | Sentence | denotes | As a consequence, a broad variety of anti-Tn monoclonal antibodies (mAbs) have been generated. |
T5 | 548-997 | Sentence | denotes | To further investigate the nature and complexity of the Tn antigen, we generated seven different anti-Tn mAbs of IgM and IgG classes raised against human Jurkat T cells, which are Tn-positive due to the low activity of T-synthase and mutation in specific chaperone Cosmc. The binding analysis of anti-Tn mAbs with the array of synthetic saccharides, glycopeptides and O-glycoproteins revealed unexpected differences in specificities of anti-Tn mAbs. |
T6 | 998-1140 | Sentence | denotes | IgM mAbs bound the terminal GalNAc residue of the Tn antigen irrespective of the peptide context or with low selectivity to the glycoproteins. |
T7 | 1141-1232 | Sentence | denotes | In contrast, IgG mAbs recognized the Tn antigen in the context of a specific peptide motif. |
T8 | 1233-1373 | Sentence | denotes | Particularly, JA3 mAb reacted to the GSPP or GSPAPP, and JA5 mAb recognized specifically the GSP motif (glycosylation sites are underlined). |
T9 | 1374-1532 | Sentence | denotes | The major O-glycan carrier proteins CD43 and CD162 and isoforms of CD45 expressed on Jurkat cells were precipitated by anti-Tn mAbs with different affinities. |
T10 | 1533-1718 | Sentence | denotes | In summary, our data suggest that Tn antigen-Ab binding capacity is determined by the peptide context of the Tn antigen, antigenic specificity of the Ab and class of the immunoglobulin. |
T11 | 1719-1893 | Sentence | denotes | The newly generated anti-Tn IgG mAbs with the strong specificity to glycoprotein CD43 can be particularly interesting for the application in leukemia diagnostics and therapy. |
T1 | 0-113 | Sentence | denotes | Analysis of Tn antigenicity with a panel of new IgM and IgG1 monoclonal antibodies raised against leukemic cells. |
T2 | 114-277 | Sentence | denotes | CD175 or Tn antigen is a carbohydrate moiety of N-acetylgalactosamine (GalNAc)α1-O- linked to the residue of amino acid serine or threonine in a polypeptide chain. |
T3 | 278-452 | Sentence | denotes | Despite the chemical simplicity of the Tn antigen, its antigenic structure is considered to be complex and the clear determinants of Tn antigenicity remain poorly understood. |
T4 | 453-547 | Sentence | denotes | As a consequence, a broad variety of anti-Tn monoclonal antibodies (mAbs) have been generated. |
T5 | 548-819 | Sentence | denotes | To further investigate the nature and complexity of the Tn antigen, we generated seven different anti-Tn mAbs of IgM and IgG classes raised against human Jurkat T cells, which are Tn-positive due to the low activity of T-synthase and mutation in specific chaperone Cosmc. |
T6 | 820-997 | Sentence | denotes | The binding analysis of anti-Tn mAbs with the array of synthetic saccharides, glycopeptides and O-glycoproteins revealed unexpected differences in specificities of anti-Tn mAbs. |
T7 | 998-1140 | Sentence | denotes | IgM mAbs bound the terminal GalNAc residue of the Tn antigen irrespective of the peptide context or with low selectivity to the glycoproteins. |
T8 | 1141-1232 | Sentence | denotes | In contrast, IgG mAbs recognized the Tn antigen in the context of a specific peptide motif. |
T9 | 1233-1373 | Sentence | denotes | Particularly, JA3 mAb reacted to the GSPP or GSPAPP, and JA5 mAb recognized specifically the GSP motif (glycosylation sites are underlined). |
T10 | 1374-1532 | Sentence | denotes | The major O-glycan carrier proteins CD43 and CD162 and isoforms of CD45 expressed on Jurkat cells were precipitated by anti-Tn mAbs with different affinities. |
T11 | 1533-1718 | Sentence | denotes | In summary, our data suggest that Tn antigen-Ab binding capacity is determined by the peptide context of the Tn antigen, antigenic specificity of the Ab and class of the immunoglobulin. |
T12 | 1719-1893 | Sentence | denotes | The newly generated anti-Tn IgG mAbs with the strong specificity to glycoprotein CD43 can be particularly interesting for the application in leukemia diagnostics and therapy. |
GlyCosmos6-Glycan-Motif-Structure
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 12-27 | https://glytoucan.org/Structures/Glycans/G57321FI | denotes | Tn antigenicity |
T2 | 123-133 | https://glytoucan.org/Structures/Glycans/G57321FI | denotes | Tn antigen |
T3 | 162-183 | https://glytoucan.org/Structures/Glycans/G27025MB | denotes | N-acetylgalactosamine |
T4 | 317-327 | https://glytoucan.org/Structures/Glycans/G57321FI | denotes | Tn antigen |
T5 | 411-426 | https://glytoucan.org/Structures/Glycans/G57321FI | denotes | Tn antigenicity |
T6 | 604-614 | https://glytoucan.org/Structures/Glycans/G57321FI | denotes | Tn antigen |
T7 | 1048-1058 | https://glytoucan.org/Structures/Glycans/G57321FI | denotes | Tn antigen |
T8 | 1178-1188 | https://glytoucan.org/Structures/Glycans/G57321FI | denotes | Tn antigen |
T9 | 1567-1577 | https://glytoucan.org/Structures/Glycans/G57321FI | denotes | Tn antigen |
T10 | 1642-1652 | https://glytoucan.org/Structures/Glycans/G57321FI | denotes | Tn antigen |
Glycosmos6-GlycoEpitope
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 123-133 | http://www.glycoepitope.jp/epitopes/EP0021 | denotes | Tn antigen |
T2 | 317-327 | http://www.glycoepitope.jp/epitopes/EP0021 | denotes | Tn antigen |
T3 | 604-614 | http://www.glycoepitope.jp/epitopes/EP0021 | denotes | Tn antigen |
T4 | 1048-1058 | http://www.glycoepitope.jp/epitopes/EP0021 | denotes | Tn antigen |
T5 | 1178-1188 | http://www.glycoepitope.jp/epitopes/EP0021 | denotes | Tn antigen |
T6 | 1567-1577 | http://www.glycoepitope.jp/epitopes/EP0021 | denotes | Tn antigen |
T7 | 1642-1652 | http://www.glycoepitope.jp/epitopes/EP0021 | denotes | Tn antigen |
PubmedHPO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 1860-1868 | HP_0001909 | denotes | leukemia |
GlycoBiology-FMA
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
_T1 | 48-51 | FMAID:167182 | denotes | IgM |
_T2 | 72-82 | FMAID:167180 | denotes | antibodies |
_T3 | 107-112 | FMAID:68646 | denotes | cells |
_T4 | 107-112 | FMAID:169002 | denotes | cells |
_T5 | 139-151 | FMAID:82737 | denotes | carbohydrate |
_T6 | 139-151 | FMAID:197276 | denotes | carbohydrate |
_T7 | 162-183 | FMAID:196780 | denotes | N-acetylgalactosamine |
_T8 | 162-183 | FMAID:82786 | denotes | N-acetylgalactosamine |
_T9 | 223-233 | FMAID:196728 | denotes | amino acid |
_T10 | 223-233 | FMAID:82739 | denotes | amino acid |
_T11 | 234-240 | FMAID:165609 | denotes | serine |
_T12 | 234-240 | FMAID:196753 | denotes | serine |
_T13 | 234-240 | FMAID:67710 | denotes | serine |
_T14 | 234-240 | FMAID:82764 | denotes | serine |
_T15 | 244-253 | FMAID:82765 | denotes | threonine |
_T16 | 244-253 | FMAID:196754 | denotes | threonine |
_T17 | 509-519 | FMAID:167180 | denotes | antibodies |
_T18 | 661-664 | FMAID:167182 | denotes | IgM |
_T19 | 669-672 | FMAID:167179 | denotes | IgG |
_T20 | 711-716 | FMAID:68646 | denotes | cells |
_T21 | 711-716 | FMAID:169002 | denotes | cells |
_T22 | 885-896 | FMAID:196733 | denotes | saccharides |
_T23 | 885-896 | FMAID:82744 | denotes | saccharides |
_T24 | 898-911 | FMAID:196778 | denotes | glycopeptides |
_T25 | 898-911 | FMAID:82784 | denotes | glycopeptides |
_T26 | 918-931 | FMAID:62925 | denotes | glycoproteins |
_T27 | 918-931 | FMAID:167256 | denotes | glycoproteins |
_T28 | 998-1001 | FMAID:167182 | denotes | IgM |
_T29 | 1126-1139 | FMAID:62925 | denotes | glycoproteins |
_T30 | 1126-1139 | FMAID:167256 | denotes | glycoproteins |
_T31 | 1154-1157 | FMAID:167179 | denotes | IgG |
_T32 | 1401-1409 | FMAID:67257 | denotes | proteins |
_T33 | 1401-1409 | FMAID:165447 | denotes | proteins |
_T34 | 1466-1471 | FMAID:68646 | denotes | cells |
_T35 | 1466-1471 | FMAID:169002 | denotes | cells |
_T36 | 1703-1717 | FMAID:167187 | denotes | immunoglobulin |
_T37 | 1703-1717 | FMAID:62872 | denotes | immunoglobulin |
_T38 | 1703-1717 | FMAID:167178 | denotes | immunoglobulin |
_T39 | 1703-1717 | FMAID:167181 | denotes | immunoglobulin |
_T40 | 1703-1717 | FMAID:62873 | denotes | immunoglobulin |
_T41 | 1703-1717 | FMAID:167185 | denotes | immunoglobulin |
_T42 | 1703-1717 | FMAID:62876 | denotes | immunoglobulin |
_T43 | 1703-1717 | FMAID:62874 | denotes | immunoglobulin |
_T44 | 1703-1717 | FMAID:167183 | denotes | immunoglobulin |
_T45 | 1703-1717 | FMAID:167177 | denotes | immunoglobulin |
_T46 | 1703-1717 | FMAID:62871 | denotes | immunoglobulin |
_T47 | 1703-1717 | FMAID:62875 | denotes | immunoglobulin |
_T48 | 1747-1750 | FMAID:167179 | denotes | IgG |
_T49 | 1787-1799 | FMAID:167256 | denotes | glycoprotein |
_T50 | 1787-1799 | FMAID:62925 | denotes | glycoprotein |
uniprot-human
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 1326-1329 | http://www.uniprot.org/uniprot/Q5JWD4 | denotes | GSP |
T2 | 1410-1414 | http://www.uniprot.org/uniprot/P16150 | denotes | CD43 |
T3 | 1800-1804 | http://www.uniprot.org/uniprot/P16150 | denotes | CD43 |
T4 | 1419-1424 | http://www.uniprot.org/uniprot/Q14242 | denotes | CD162 |
T5 | 1441-1445 | http://www.uniprot.org/uniprot/P08575 | denotes | CD45 |
uniprot-mouse
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 813-818 | http://www.uniprot.org/uniprot/Q9JMG2 | denotes | Cosmc |
T2 | 1410-1414 | http://www.uniprot.org/uniprot/P15702 | denotes | CD43 |
T3 | 1800-1804 | http://www.uniprot.org/uniprot/P15702 | denotes | CD43 |
T4 | 1419-1424 | http://www.uniprot.org/uniprot/Q62170 | denotes | CD162 |
T5 | 1441-1445 | http://www.uniprot.org/uniprot/P06800 | denotes | CD45 |
GlycoBiology-NCBITAXON
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 61-71 | http://purl.bioontology.org/ontology/NCBITAXON/608684 | denotes | monoclonal |
T2 | 107-112 | http://purl.bioontology.org/ontology/STY/T025 | denotes | cells |
T3 | 498-508 | http://purl.bioontology.org/ontology/NCBITAXON/608684 | denotes | monoclonal |
T4 | 711-716 | http://purl.bioontology.org/ontology/STY/T025 | denotes | cells |
T5 | 1466-1471 | http://purl.bioontology.org/ontology/STY/T025 | denotes | cells |
GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 1337-1350 | http://purl.obolibrary.org/obo/GO_0070085 | denotes | glycosylation |
GO-MF
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 72-82 | http://purl.obolibrary.org/obo/GO_0003823 | denotes | antibodies |
T2 | 509-519 | http://purl.obolibrary.org/obo/GO_0003823 | denotes | antibodies |
T3 | 824-831 | http://purl.obolibrary.org/obo/GO_0070026 | denotes | binding |
T4 | 1581-1588 | http://purl.obolibrary.org/obo/GO_0070026 | denotes | binding |
T5 | 824-831 | http://purl.obolibrary.org/obo/GO_0003680 | denotes | binding |
T6 | 1581-1588 | http://purl.obolibrary.org/obo/GO_0003680 | denotes | binding |
T7 | 824-831 | http://purl.obolibrary.org/obo/GO_0017091 | denotes | binding |
T8 | 1581-1588 | http://purl.obolibrary.org/obo/GO_0017091 | denotes | binding |
T9 | 824-831 | http://purl.obolibrary.org/obo/GO_0005488 | denotes | binding |
T10 | 1581-1588 | http://purl.obolibrary.org/obo/GO_0005488 | denotes | binding |
T11 | 1703-1717 | http://purl.obolibrary.org/obo/GO_0003823 | denotes | immunoglobulin |
GO-CC
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 56-60 | http://purl.obolibrary.org/obo/GO_0071735 | denotes | IgG1 |
T2 | 107-112 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cells |
T3 | 711-716 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cells |
T4 | 1466-1471 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cells |
Allie
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
SS1_22143985_3_0 | 498-519 | expanded | denotes | monoclonal antibodies |
SS2_22143985_3_0 | 521-525 | abbr | denotes | mAbs |
AE1_22143985_3_0 | SS1_22143985_3_0 | SS2_22143985_3_0 | abbreviatedTo | monoclonal antibodies,mAbs |
EDAM-topics
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 15-27 | http://edamontology.org/topic_2830 | denotes | antigenicity |
T2 | 126-133 | http://edamontology.org/topic_2830 | denotes | antigen |
T3 | 139-151 | http://edamontology.org/topic_0152 | denotes | carbohydrate |
T4 | 223-233 | http://edamontology.org/topic_0154 | denotes | amino acid |
T5 | 320-327 | http://edamontology.org/topic_2830 | denotes | antigen |
T6 | 333-342 | http://edamontology.org/topic_2830 | denotes | antigenic |
T7 | 414-426 | http://edamontology.org/topic_2830 | denotes | antigenicity |
T8 | 607-614 | http://edamontology.org/topic_2830 | denotes | antigen |
T9 | 696-701 | http://edamontology.org/topic_2815 | denotes | human |
T10 | 782-790 | http://edamontology.org/topic_0199 | denotes | mutation |
T11 | 1017-1025 | http://edamontology.org/topic_0749 | denotes | terminal |
T12 | 1051-1058 | http://edamontology.org/topic_2830 | denotes | antigen |
T13 | 1079-1086 | http://edamontology.org/topic_0154 | denotes | peptide |
T14 | 1181-1188 | http://edamontology.org/topic_2830 | denotes | antigen |
T15 | 1218-1225 | http://edamontology.org/topic_0154 | denotes | peptide |
T16 | 1226-1231 | http://edamontology.org/topic_0158 | denotes | motif |
T17 | 1330-1335 | http://edamontology.org/topic_0158 | denotes | motif |
T18 | 1401-1409 | http://edamontology.org/topic_0078 | denotes | proteins |
T19 | 1570-1577 | http://edamontology.org/topic_2830 | denotes | antigen |
T20 | 1619-1626 | http://edamontology.org/topic_0154 | denotes | peptide |
T21 | 1645-1652 | http://edamontology.org/topic_2830 | denotes | antigen |
T22 | 1654-1663 | http://edamontology.org/topic_2830 | denotes | antigenic |
EDAM-DFO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 0-8 | http://edamontology.org/operation_2945 | denotes | Analysis |
T2 | 212-219 | http://edamontology.org/data_1756 | denotes | residue |
T3 | 259-276 | http://edamontology.org/data_1008 | denotes | polypeptide chain |
T4 | 343-352 | http://edamontology.org/data_0883 | denotes | structure |
T5 | 343-355 | http://edamontology.org/data_1070 | denotes | structure is |
T6 | 537-546 | http://edamontology.org/operation_3429 | denotes | generated |
T7 | 619-628 | http://edamontology.org/operation_3429 | denotes | generated |
T8 | 832-840 | http://edamontology.org/operation_2945 | denotes | analysis |
T9 | 866-871 | http://edamontology.org/data_2082 | denotes | array |
T10 | 1033-1040 | http://edamontology.org/data_1756 | denotes | residue |
T11 | 1079-1086 | http://edamontology.org/data_2906 | denotes | peptide |
T12 | 1218-1225 | http://edamontology.org/data_2906 | denotes | peptide |
T13 | 1401-1409 | http://edamontology.org/data_1467 | denotes | proteins |
T14 | 1401-1409 | http://edamontology.org/format_1208 | denotes | proteins |
T15 | 1549-1553 | http://edamontology.org/data_0006 | denotes | data |
T16 | 1619-1626 | http://edamontology.org/data_2906 | denotes | peptide |
T17 | 1729-1738 | http://edamontology.org/operation_3429 | denotes | generated |
GlyTouCan-IUPAC
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
GlycanIUPAC_T1 | 185-191 | "http://rdf.glycoinfo.org/glycan/G23425WZ" | denotes | GalNAc |
GlycanIUPAC_T2 | 1026-1032 | "http://rdf.glycoinfo.org/glycan/G23425WZ" | denotes | GalNAc |
GlycanIUPAC_T3 | 185-191 | "http://rdf.glycoinfo.org/glycan/G02874VH" | denotes | GalNAc |
GlycanIUPAC_T4 | 1026-1032 | "http://rdf.glycoinfo.org/glycan/G02874VH" | denotes | GalNAc |
GlycanIUPAC_T5 | 185-191 | "http://rdf.glycoinfo.org/glycan/G99699DW" | denotes | GalNAc |
GlycanIUPAC_T6 | 1026-1032 | "http://rdf.glycoinfo.org/glycan/G99699DW" | denotes | GalNAc |
GlycanIUPAC_T7 | 185-191 | "http://rdf.glycoinfo.org/glycan/G22074RM" | denotes | GalNAc |
GlycanIUPAC_T8 | 1026-1032 | "http://rdf.glycoinfo.org/glycan/G22074RM" | denotes | GalNAc |
GlycanIUPAC_T9 | 185-191 | "http://rdf.glycoinfo.org/glycan/G48535VZ" | denotes | GalNAc |
GlycanIUPAC_T10 | 1026-1032 | "http://rdf.glycoinfo.org/glycan/G48535VZ" | denotes | GalNAc |
GlycanIUPAC_T11 | 185-191 | "http://rdf.glycoinfo.org/glycan/G39738WL" | denotes | GalNAc |
GlycanIUPAC_T12 | 1026-1032 | "http://rdf.glycoinfo.org/glycan/G39738WL" | denotes | GalNAc |
GlycanIUPAC_T13 | 185-191 | "http://rdf.glycoinfo.org/glycan/G42313WU" | denotes | GalNAc |
GlycanIUPAC_T14 | 1026-1032 | "http://rdf.glycoinfo.org/glycan/G42313WU" | denotes | GalNAc |
GlycanIUPAC_T15 | 185-191 | "http://rdf.glycoinfo.org/glycan/G00393CK" | denotes | GalNAc |
GlycanIUPAC_T16 | 1026-1032 | "http://rdf.glycoinfo.org/glycan/G00393CK" | denotes | GalNAc |
GlycanIUPAC_T17 | 185-191 | "http://rdf.glycoinfo.org/glycan/G42649EX" | denotes | GalNAc |
GlycanIUPAC_T18 | 1026-1032 | "http://rdf.glycoinfo.org/glycan/G42649EX" | denotes | GalNAc |
GlycanIUPAC_T19 | 185-191 | "http://rdf.glycoinfo.org/glycan/G46880SB" | denotes | GalNAc |
GlycanIUPAC_T20 | 1026-1032 | "http://rdf.glycoinfo.org/glycan/G46880SB" | denotes | GalNAc |
GlycanIUPAC_T21 | 185-191 | "http://rdf.glycoinfo.org/glycan/G75599IR" | denotes | GalNAc |
GlycanIUPAC_T22 | 1026-1032 | "http://rdf.glycoinfo.org/glycan/G75599IR" | denotes | GalNAc |
GlycanIUPAC_T23 | 185-191 | "http://rdf.glycoinfo.org/glycan/G58985MU" | denotes | GalNAc |
GlycanIUPAC_T24 | 1026-1032 | "http://rdf.glycoinfo.org/glycan/G58985MU" | denotes | GalNAc |
GlycanIUPAC_T25 | 185-191 | "http://rdf.glycoinfo.org/glycan/G92517PO" | denotes | GalNAc |
GlycanIUPAC_T26 | 1026-1032 | "http://rdf.glycoinfo.org/glycan/G92517PO" | denotes | GalNAc |
GlycanIUPAC_T27 | 185-191 | "http://rdf.glycoinfo.org/glycan/G88512YL" | denotes | GalNAc |
GlycanIUPAC_T28 | 1026-1032 | "http://rdf.glycoinfo.org/glycan/G88512YL" | denotes | GalNAc |
GlycanIUPAC_T29 | 185-191 | "http://rdf.glycoinfo.org/glycan/G41473NX" | denotes | GalNAc |
GlycanIUPAC_T30 | 1026-1032 | "http://rdf.glycoinfo.org/glycan/G41473NX" | denotes | GalNAc |
GlycanIUPAC_T31 | 185-191 | "http://rdf.glycoinfo.org/glycan/G71089RB" | denotes | GalNAc |
GlycanIUPAC_T32 | 1026-1032 | "http://rdf.glycoinfo.org/glycan/G71089RB" | denotes | GalNAc |
GlycanIUPAC_T33 | 185-191 | "http://rdf.glycoinfo.org/glycan/G73485GZ" | denotes | GalNAc |
GlycanIUPAC_T34 | 1026-1032 | "http://rdf.glycoinfo.org/glycan/G73485GZ" | denotes | GalNAc |
GlycanIUPAC_T35 | 185-191 | "http://rdf.glycoinfo.org/glycan/G61406KC" | denotes | GalNAc |
GlycanIUPAC_T36 | 1026-1032 | "http://rdf.glycoinfo.org/glycan/G61406KC" | denotes | GalNAc |
GlycanIUPAC_T37 | 185-191 | "http://rdf.glycoinfo.org/glycan/G34412GZ" | denotes | GalNAc |
GlycanIUPAC_T38 | 1026-1032 | "http://rdf.glycoinfo.org/glycan/G34412GZ" | denotes | GalNAc |
GlycanIUPAC_T39 | 185-191 | "http://rdf.glycoinfo.org/glycan/G67209FP" | denotes | GalNAc |
GlycanIUPAC_T40 | 1026-1032 | "http://rdf.glycoinfo.org/glycan/G67209FP" | denotes | GalNAc |
GlycanIUPAC_T41 | 185-191 | "http://rdf.glycoinfo.org/glycan/G61442IL" | denotes | GalNAc |
GlycanIUPAC_T42 | 1026-1032 | "http://rdf.glycoinfo.org/glycan/G61442IL" | denotes | GalNAc |
GlycanIUPAC_T43 | 185-191 | "http://rdf.glycoinfo.org/glycan/G93729MV" | denotes | GalNAc |
GlycanIUPAC_T44 | 1026-1032 | "http://rdf.glycoinfo.org/glycan/G93729MV" | denotes | GalNAc |
GlycanIUPAC_T45 | 185-191 | "http://rdf.glycoinfo.org/glycan/G92144AE" | denotes | GalNAc |
GlycanIUPAC_T46 | 1026-1032 | "http://rdf.glycoinfo.org/glycan/G92144AE" | denotes | GalNAc |
Lectin
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
Lectin_T1 | 12-14 | https://acgg.asia/db/lfdb/LfDB0021 | denotes | Tn |
Lectin_T2 | 123-125 | https://acgg.asia/db/lfdb/LfDB0021 | denotes | Tn |
Lectin_T3 | 317-319 | https://acgg.asia/db/lfdb/LfDB0021 | denotes | Tn |
Lectin_T4 | 411-413 | https://acgg.asia/db/lfdb/LfDB0021 | denotes | Tn |
Lectin_T5 | 495-497 | https://acgg.asia/db/lfdb/LfDB0021 | denotes | Tn |
Lectin_T6 | 604-606 | https://acgg.asia/db/lfdb/LfDB0021 | denotes | Tn |
Lectin_T7 | 650-652 | https://acgg.asia/db/lfdb/LfDB0021 | denotes | Tn |
Lectin_T8 | 728-730 | https://acgg.asia/db/lfdb/LfDB0021 | denotes | Tn |
Lectin_T9 | 849-851 | https://acgg.asia/db/lfdb/LfDB0021 | denotes | Tn |
Lectin_T10 | 989-991 | https://acgg.asia/db/lfdb/LfDB0021 | denotes | Tn |
Lectin_T11 | 1048-1050 | https://acgg.asia/db/lfdb/LfDB0021 | denotes | Tn |
Lectin_T12 | 1178-1180 | https://acgg.asia/db/lfdb/LfDB0021 | denotes | Tn |
Lectin_T13 | 1498-1500 | https://acgg.asia/db/lfdb/LfDB0021 | denotes | Tn |
Lectin_T14 | 1567-1569 | https://acgg.asia/db/lfdb/LfDB0021 | denotes | Tn |
Lectin_T15 | 1642-1644 | https://acgg.asia/db/lfdb/LfDB0021 | denotes | Tn |
Lectin_T16 | 1744-1746 | https://acgg.asia/db/lfdb/LfDB0021 | denotes | Tn |
GlycoBiology-Epitope
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
PD-GlycoEpitope-B_T1 | 12-27 | http://www.glycoepitope.jp/epitopes/EP0021 | denotes | Tn antigenicity |
PD-GlycoEpitope-B_T2 | 123-133 | http://www.glycoepitope.jp/epitopes/EP0021 | denotes | Tn antigen |
PD-GlycoEpitope-B_T3 | 317-327 | http://www.glycoepitope.jp/epitopes/EP0021 | denotes | Tn antigen |
PD-GlycoEpitope-B_T4 | 411-426 | http://www.glycoepitope.jp/epitopes/EP0021 | denotes | Tn antigenicity |
PD-GlycoEpitope-B_T5 | 604-614 | http://www.glycoepitope.jp/epitopes/EP0021 | denotes | Tn antigen |
PD-GlycoEpitope-B_T6 | 1048-1058 | http://www.glycoepitope.jp/epitopes/EP0021 | denotes | Tn antigen |
PD-GlycoEpitope-B_T7 | 1178-1188 | http://www.glycoepitope.jp/epitopes/EP0021 | denotes | Tn antigen |
PD-GlycoEpitope-B_T8 | 1567-1577 | http://www.glycoepitope.jp/epitopes/EP0021 | denotes | Tn antigen |
PD-GlycoEpitope-B_T9 | 1642-1652 | http://www.glycoepitope.jp/epitopes/EP0021 | denotes | Tn antigen |
mondo_disease
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T1 | 1860-1868 | Disease | denotes | leukemia | http://purl.obolibrary.org/obo/MONDO_0005059 |
HP-phenotype
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T1 | 1860-1868 | Phenotype | denotes | leukemia | HP:0001909 |
Glycan-GlyCosmos
Id | Subject | Object | Predicate | Lexical cue | image |
---|---|---|---|---|---|
T1 | 123-133 | Glycan | denotes | Tn antigen | https://api.glycosmos.org/wurcs2image/latest/png/binary/G57321FI |
T2 | 185-191 | Glycan | denotes | GalNAc | https://api.glycosmos.org/wurcs2image/latest/png/binary/G39738WL |
T3 | 317-327 | Glycan | denotes | Tn antigen | https://api.glycosmos.org/wurcs2image/latest/png/binary/G57321FI |
T4 | 604-614 | Glycan | denotes | Tn antigen | https://api.glycosmos.org/wurcs2image/latest/png/binary/G57321FI |
T5 | 1026-1032 | Glycan | denotes | GalNAc | https://api.glycosmos.org/wurcs2image/latest/png/binary/G39738WL |
T6 | 1048-1058 | Glycan | denotes | Tn antigen | https://api.glycosmos.org/wurcs2image/latest/png/binary/G57321FI |
T7 | 1178-1188 | Glycan | denotes | Tn antigen | https://api.glycosmos.org/wurcs2image/latest/png/binary/G57321FI |
T8 | 1567-1577 | Glycan | denotes | Tn antigen | https://api.glycosmos.org/wurcs2image/latest/png/binary/G57321FI |
T9 | 1642-1652 | Glycan | denotes | Tn antigen | https://api.glycosmos.org/wurcs2image/latest/png/binary/G57321FI |
GlyCosmos-GlycoEpitope
Id | Subject | Object | Predicate | Lexical cue | glycoepitope_id |
---|---|---|---|---|---|
T1 | 123-133 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | Tn antigen | http://www.glycoepitope.jp/epitopes/EP0021 |
T2 | 317-327 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | Tn antigen | http://www.glycoepitope.jp/epitopes/EP0021 |
T3 | 604-614 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | Tn antigen | http://www.glycoepitope.jp/epitopes/EP0021 |
T4 | 1048-1058 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | Tn antigen | http://www.glycoepitope.jp/epitopes/EP0021 |
T5 | 1178-1188 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | Tn antigen | http://www.glycoepitope.jp/epitopes/EP0021 |
T6 | 1567-1577 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | Tn antigen | http://www.glycoepitope.jp/epitopes/EP0021 |
T7 | 1642-1652 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | Tn antigen | http://www.glycoepitope.jp/epitopes/EP0021 |
GlyCosmos15-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T1 | 1860-1868 | Phenotype | denotes | leukemia | HP:0001909 |
GlyCosmos15-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T1 | 1860-1868 | Disease | denotes | leukemia | http://purl.obolibrary.org/obo/MONDO_0005059 |
GlyCosmos15-NCBITAXON
Id | Subject | Object | Predicate | Lexical cue | db_id |
---|---|---|---|---|---|
T1 | 696-701 | OrganismTaxon | denotes | human | 9606 |
GlyCosmos15-CL
Id | Subject | Object | Predicate | Lexical cue | cl_id |
---|---|---|---|---|---|
T1 | 709-716 | Cell | denotes | T cells | http://purl.obolibrary.org/obo/CL:0000084 |
sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
TextSentencer_T1 | 0-113 | Sentence | denotes | Analysis of Tn antigenicity with a panel of new IgM and IgG1 monoclonal antibodies raised against leukemic cells. |
TextSentencer_T2 | 114-277 | Sentence | denotes | CD175 or Tn antigen is a carbohydrate moiety of N-acetylgalactosamine (GalNAc)α1-O- linked to the residue of amino acid serine or threonine in a polypeptide chain. |
TextSentencer_T3 | 278-452 | Sentence | denotes | Despite the chemical simplicity of the Tn antigen, its antigenic structure is considered to be complex and the clear determinants of Tn antigenicity remain poorly understood. |
TextSentencer_T4 | 453-547 | Sentence | denotes | As a consequence, a broad variety of anti-Tn monoclonal antibodies (mAbs) have been generated. |
TextSentencer_T5 | 548-819 | Sentence | denotes | To further investigate the nature and complexity of the Tn antigen, we generated seven different anti-Tn mAbs of IgM and IgG classes raised against human Jurkat T cells, which are Tn-positive due to the low activity of T-synthase and mutation in specific chaperone Cosmc. |
TextSentencer_T6 | 820-997 | Sentence | denotes | The binding analysis of anti-Tn mAbs with the array of synthetic saccharides, glycopeptides and O-glycoproteins revealed unexpected differences in specificities of anti-Tn mAbs. |
TextSentencer_T7 | 998-1140 | Sentence | denotes | IgM mAbs bound the terminal GalNAc residue of the Tn antigen irrespective of the peptide context or with low selectivity to the glycoproteins. |
TextSentencer_T8 | 1141-1232 | Sentence | denotes | In contrast, IgG mAbs recognized the Tn antigen in the context of a specific peptide motif. |
TextSentencer_T9 | 1233-1373 | Sentence | denotes | Particularly, JA3 mAb reacted to the GSPP or GSPAPP, and JA5 mAb recognized specifically the GSP motif (glycosylation sites are underlined). |
TextSentencer_T10 | 1374-1532 | Sentence | denotes | The major O-glycan carrier proteins CD43 and CD162 and isoforms of CD45 expressed on Jurkat cells were precipitated by anti-Tn mAbs with different affinities. |
TextSentencer_T11 | 1533-1718 | Sentence | denotes | In summary, our data suggest that Tn antigen-Ab binding capacity is determined by the peptide context of the Tn antigen, antigenic specificity of the Ab and class of the immunoglobulin. |
TextSentencer_T12 | 1719-1893 | Sentence | denotes | The newly generated anti-Tn IgG mAbs with the strong specificity to glycoprotein CD43 can be particularly interesting for the application in leukemia diagnostics and therapy. |
T1 | 0-113 | Sentence | denotes | Analysis of Tn antigenicity with a panel of new IgM and IgG1 monoclonal antibodies raised against leukemic cells. |
T2 | 114-277 | Sentence | denotes | CD175 or Tn antigen is a carbohydrate moiety of N-acetylgalactosamine (GalNAc)α1-O- linked to the residue of amino acid serine or threonine in a polypeptide chain. |
T3 | 278-452 | Sentence | denotes | Despite the chemical simplicity of the Tn antigen, its antigenic structure is considered to be complex and the clear determinants of Tn antigenicity remain poorly understood. |
T4 | 453-547 | Sentence | denotes | As a consequence, a broad variety of anti-Tn monoclonal antibodies (mAbs) have been generated. |
T5 | 548-997 | Sentence | denotes | To further investigate the nature and complexity of the Tn antigen, we generated seven different anti-Tn mAbs of IgM and IgG classes raised against human Jurkat T cells, which are Tn-positive due to the low activity of T-synthase and mutation in specific chaperone Cosmc. The binding analysis of anti-Tn mAbs with the array of synthetic saccharides, glycopeptides and O-glycoproteins revealed unexpected differences in specificities of anti-Tn mAbs. |
T6 | 998-1140 | Sentence | denotes | IgM mAbs bound the terminal GalNAc residue of the Tn antigen irrespective of the peptide context or with low selectivity to the glycoproteins. |
T7 | 1141-1232 | Sentence | denotes | In contrast, IgG mAbs recognized the Tn antigen in the context of a specific peptide motif. |
T8 | 1233-1373 | Sentence | denotes | Particularly, JA3 mAb reacted to the GSPP or GSPAPP, and JA5 mAb recognized specifically the GSP motif (glycosylation sites are underlined). |
T9 | 1374-1532 | Sentence | denotes | The major O-glycan carrier proteins CD43 and CD162 and isoforms of CD45 expressed on Jurkat cells were precipitated by anti-Tn mAbs with different affinities. |
T10 | 1533-1718 | Sentence | denotes | In summary, our data suggest that Tn antigen-Ab binding capacity is determined by the peptide context of the Tn antigen, antigenic specificity of the Ab and class of the immunoglobulin. |
T11 | 1719-1893 | Sentence | denotes | The newly generated anti-Tn IgG mAbs with the strong specificity to glycoprotein CD43 can be particularly interesting for the application in leukemia diagnostics and therapy. |
T1 | 0-113 | Sentence | denotes | Analysis of Tn antigenicity with a panel of new IgM and IgG1 monoclonal antibodies raised against leukemic cells. |
T2 | 114-277 | Sentence | denotes | CD175 or Tn antigen is a carbohydrate moiety of N-acetylgalactosamine (GalNAc)α1-O- linked to the residue of amino acid serine or threonine in a polypeptide chain. |
T3 | 278-452 | Sentence | denotes | Despite the chemical simplicity of the Tn antigen, its antigenic structure is considered to be complex and the clear determinants of Tn antigenicity remain poorly understood. |
T4 | 453-547 | Sentence | denotes | As a consequence, a broad variety of anti-Tn monoclonal antibodies (mAbs) have been generated. |
T5 | 548-819 | Sentence | denotes | To further investigate the nature and complexity of the Tn antigen, we generated seven different anti-Tn mAbs of IgM and IgG classes raised against human Jurkat T cells, which are Tn-positive due to the low activity of T-synthase and mutation in specific chaperone Cosmc. |
T6 | 820-997 | Sentence | denotes | The binding analysis of anti-Tn mAbs with the array of synthetic saccharides, glycopeptides and O-glycoproteins revealed unexpected differences in specificities of anti-Tn mAbs. |
T7 | 998-1140 | Sentence | denotes | IgM mAbs bound the terminal GalNAc residue of the Tn antigen irrespective of the peptide context or with low selectivity to the glycoproteins. |
T8 | 1141-1232 | Sentence | denotes | In contrast, IgG mAbs recognized the Tn antigen in the context of a specific peptide motif. |
T9 | 1233-1373 | Sentence | denotes | Particularly, JA3 mAb reacted to the GSPP or GSPAPP, and JA5 mAb recognized specifically the GSP motif (glycosylation sites are underlined). |
T10 | 1374-1532 | Sentence | denotes | The major O-glycan carrier proteins CD43 and CD162 and isoforms of CD45 expressed on Jurkat cells were precipitated by anti-Tn mAbs with different affinities. |
T11 | 1533-1718 | Sentence | denotes | In summary, our data suggest that Tn antigen-Ab binding capacity is determined by the peptide context of the Tn antigen, antigenic specificity of the Ab and class of the immunoglobulin. |
T12 | 1719-1893 | Sentence | denotes | The newly generated anti-Tn IgG mAbs with the strong specificity to glycoprotein CD43 can be particularly interesting for the application in leukemia diagnostics and therapy. |
GlyCosmos15-Sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 0-113 | Sentence | denotes | Analysis of Tn antigenicity with a panel of new IgM and IgG1 monoclonal antibodies raised against leukemic cells. |
T2 | 114-277 | Sentence | denotes | CD175 or Tn antigen is a carbohydrate moiety of N-acetylgalactosamine (GalNAc)α1-O- linked to the residue of amino acid serine or threonine in a polypeptide chain. |
T3 | 278-452 | Sentence | denotes | Despite the chemical simplicity of the Tn antigen, its antigenic structure is considered to be complex and the clear determinants of Tn antigenicity remain poorly understood. |
T4 | 453-547 | Sentence | denotes | As a consequence, a broad variety of anti-Tn monoclonal antibodies (mAbs) have been generated. |
T5 | 548-997 | Sentence | denotes | To further investigate the nature and complexity of the Tn antigen, we generated seven different anti-Tn mAbs of IgM and IgG classes raised against human Jurkat T cells, which are Tn-positive due to the low activity of T-synthase and mutation in specific chaperone Cosmc. The binding analysis of anti-Tn mAbs with the array of synthetic saccharides, glycopeptides and O-glycoproteins revealed unexpected differences in specificities of anti-Tn mAbs. |
T6 | 998-1140 | Sentence | denotes | IgM mAbs bound the terminal GalNAc residue of the Tn antigen irrespective of the peptide context or with low selectivity to the glycoproteins. |
T7 | 1141-1232 | Sentence | denotes | In contrast, IgG mAbs recognized the Tn antigen in the context of a specific peptide motif. |
T8 | 1233-1373 | Sentence | denotes | Particularly, JA3 mAb reacted to the GSPP or GSPAPP, and JA5 mAb recognized specifically the GSP motif (glycosylation sites are underlined). |
T9 | 1374-1532 | Sentence | denotes | The major O-glycan carrier proteins CD43 and CD162 and isoforms of CD45 expressed on Jurkat cells were precipitated by anti-Tn mAbs with different affinities. |
T10 | 1533-1718 | Sentence | denotes | In summary, our data suggest that Tn antigen-Ab binding capacity is determined by the peptide context of the Tn antigen, antigenic specificity of the Ab and class of the immunoglobulin. |
T11 | 1719-1893 | Sentence | denotes | The newly generated anti-Tn IgG mAbs with the strong specificity to glycoprotein CD43 can be particularly interesting for the application in leukemia diagnostics and therapy. |
GlyCosmos15-Glycan
Id | Subject | Object | Predicate | Lexical cue | image |
---|---|---|---|---|---|
T1 | 123-133 | Glycan | denotes | Tn antigen | https://api.glycosmos.org/wurcs2image/latest/png/binary/G57321FI |
T2 | 185-191 | Glycan | denotes | GalNAc | https://api.glycosmos.org/wurcs2image/latest/png/binary/G39738WL |
T3 | 317-327 | Glycan | denotes | Tn antigen | https://api.glycosmos.org/wurcs2image/latest/png/binary/G57321FI |
T4 | 604-614 | Glycan | denotes | Tn antigen | https://api.glycosmos.org/wurcs2image/latest/png/binary/G57321FI |
T5 | 1026-1032 | Glycan | denotes | GalNAc | https://api.glycosmos.org/wurcs2image/latest/png/binary/G39738WL |
T6 | 1048-1058 | Glycan | denotes | Tn antigen | https://api.glycosmos.org/wurcs2image/latest/png/binary/G57321FI |
T7 | 1178-1188 | Glycan | denotes | Tn antigen | https://api.glycosmos.org/wurcs2image/latest/png/binary/G57321FI |
T8 | 1567-1577 | Glycan | denotes | Tn antigen | https://api.glycosmos.org/wurcs2image/latest/png/binary/G57321FI |
T9 | 1642-1652 | Glycan | denotes | Tn antigen | https://api.glycosmos.org/wurcs2image/latest/png/binary/G57321FI |
GlyCosmos15-GlycoEpitope
Id | Subject | Object | Predicate | Lexical cue | glycoepitope_id |
---|---|---|---|---|---|
T1 | 123-133 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | Tn antigen | http://www.glycoepitope.jp/epitopes/EP0021 |
T2 | 317-327 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | Tn antigen | http://www.glycoepitope.jp/epitopes/EP0021 |
T3 | 604-614 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | Tn antigen | http://www.glycoepitope.jp/epitopes/EP0021 |
T4 | 1048-1058 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | Tn antigen | http://www.glycoepitope.jp/epitopes/EP0021 |
T5 | 1178-1188 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | Tn antigen | http://www.glycoepitope.jp/epitopes/EP0021 |
T6 | 1567-1577 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | Tn antigen | http://www.glycoepitope.jp/epitopes/EP0021 |
T7 | 1642-1652 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | Tn antigen | http://www.glycoepitope.jp/epitopes/EP0021 |
NCBITAXON
Id | Subject | Object | Predicate | Lexical cue | db_id |
---|---|---|---|---|---|
T1 | 696-701 | OrganismTaxon | denotes | human | 9606 |
CL-cell
Id | Subject | Object | Predicate | Lexical cue | cl_id |
---|---|---|---|---|---|
T1 | 709-716 | Cell | denotes | T cells | http://purl.obolibrary.org/obo/CL:0000084 |